TruWealth Advisors’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,075
Closed -$214K 137
2022
Q2
$214K Buy
+2,075
New +$223K 0.02% 126
2022
Q1
Sell
-1,730
Closed -$215K 128
2021
Q4
$215K Hold
1,730
0.02% 116
2021
Q3
$206K Sell
1,730
-102
-6% -$12.5K 0.02% 114
2021
Q2
$215K Sell
1,832
-1,171
-39% -$134K 0.03% 108
2021
Q1
$326K Sell
3,003
-851
-22% -$93.1K 0.04% 81
2020
Q4
$415K Buy
+3,854
New +$392K 0.06% 76

Other funds holding FXH

TruWealth Advisors's FXH Position: Q3 2022 in Review

TruWealth Advisors sold out of First Trust Health Care AlphaDEX Fund (FXH) in Q3 2022, closing a stake of 2,075 shares — an estimated $214K sold.

TruWealth Advisors first reported a position in FXH in Q4 2020 and held it in 6 quarters. The position peaked at $415K in Q4 2020. 247 funds tracked by Wall St. Rank hold FXH as of Q3 2022.

  • TruWealth Advisors reported no remaining First Trust Health Care AlphaDEX Fund position as of Q3 2022 after selling out during the quarter.
  • TruWealth Advisors sold 2,075 First Trust Health Care AlphaDEX Fund shares in Q3 2022, an estimated $214K.
  • TruWealth Advisors first reported a position in First Trust Health Care AlphaDEX Fund in Q4 2020 and held it in 6 quarters.
  • TruWealth Advisors's First Trust Health Care AlphaDEX Fund position peaked at $415K in Q4 2020.
  • 247 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q3 2022.

Based on TruWealth Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.